Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Sartar Therapeutics Logo
Sartar Therapeutics Growth Score
82
CB Rank
755682
Heat Score
60
Targeted therapy for rare gastrointestinal cancer, GIST based on a discovery of novel drug targets in cancer and drug repositioning.
Founded
obfuscation
Private Helsinki, Southern Finland, Finland1-10 sartartherapeutics.com/
Biotechnology
Overview

Sartar Therapeutics
Growth Score
82
Heat Score
60

Growth Score82
-7 pts
in past quarter
Heat Score 60
-22 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Sartar Therapeutics

CB Rank
755682
Targeted therapy for rare gastrointestinal cancer, GIST based on a discovery of novel drug targets in cancer and drug repositioning.
Founded
obfuscation
Private Helsinki, Southern Finland, Finland1-10 sartartherapeutics.com/
Biotechnology

Details

Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

SAR003
SAR003 is a targeted therapy for cancers expressing the PDE3A gene, particularly gastrointestinal stromal tumors (GIST), functioning as a molecular glue to induce cancer cell death.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 3
News
Technology
View Tech Report

Monthly Web Visits

827
129.09%
 in past month

Active Website Tech Count

8Sartar Therapeutics is actively using 8 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, DNSSEC, and  Mobile Non Scaleable Content.

Total IP

2The intellectual property of Sartar Therapeutics includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Sartar Therapeutics's headquarters? Sartar Therapeutics is located in Helsinki, Southern Finland, Finland.Who are Sartar Therapeutics's competitors? Alternatives and possible competitors to Sartar Therapeutics may include Eli Lilly, Pfizer, and  Novartis.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|